section name header

Answer

Back

Absolutely. In the early 1990s, the Food and Drug Administration (FDA) removed silicone implants from use for cosmetic purposes due to concerns about the development of autoimmune disease or connective tissue disease from silicone leakage. Many retrospective studies subsequently dispelled this concern, also disproving causal links to cancer. Additionally, the silicone implants currently used have a thicker shell and more dense gel, which are believed to decrease the rate of implant rupture. All patients who consent to it are enrolled in a clinical trial for surveillance by the breast implant manufacturers (Rothrock & McEwen, 2006; FDA, 2011).